← Back to Search

Special Pre-Surgery Diet for Head and Neck Cancer

N/A
Waitlist Available
Led By Carissa M. Thomas, MD, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of moderate (Stage B) or severe (Stage C) malnutrition, based on the patient-generated subjective global assessment (PG-SGA)
Ability to consent for themselves
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline - 6 months
Awards & highlights

Study Summary

This trial will test whether a special diet before surgery can improve outcomes for people with head and neck cancer.

Who is the study for?
Adults diagnosed with head and neck cancer preparing for major surgery, who are moderately or severely malnourished. They must understand English and be able to consent. Excluded are those under 18, pregnant, with autoimmune disorders requiring medication, chronic immunosuppression, advanced kidney disease, cirrhosis, pancreatitis or allergies to fish oil.Check my eligibility
What is being tested?
The study is testing the effects of a nutritional drink called Nestlé Impact Advanced Recovery on the gut microbiome and surgical outcomes in patients undergoing major surgery for head & neck cancers.See study design
What are the potential side effects?
While not explicitly stated here, potential side effects may include digestive discomfort or allergic reactions related to ingredients in the nutritional drink such as fish oil.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with moderate to severe malnutrition.
Select...
I can make my own medical decisions.
Select...
I have had major surgery involving tissue reconstruction.
Select...
I have head or neck cancer and will undergo major surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline - 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline - 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Define changes in the gut microbiome in malnourished patients with head and neck cancer after a pre-operative nutrition intervention via analyses of stool samples.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nutrition intervention groupExperimental Treatment1 Intervention
Participants will receive Nestlé Impact Advanced Recovery Immunonutrition two times daily for 5 days leading up to the date of surgery. Nestlé Impact Advanced Recovery will be administered either orally or through a feeding tube.

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,280,024 Total Patients Enrolled
Carissa M. Thomas, MD, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Nestlé Impact Advanced Recovery Clinical Trial Eligibility Overview. Trial Name: NCT05061316 — N/A
Head and Neck Cancers Research Study Groups: Nutrition intervention group
Head and Neck Cancers Clinical Trial 2023: Nestlé Impact Advanced Recovery Highlights & Side Effects. Trial Name: NCT05061316 — N/A
Nestlé Impact Advanced Recovery 2023 Treatment Timeline for Medical Study. Trial Name: NCT05061316 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been included in this clinical experiment?

"Affirmative, the data accessible on clinicaltrials.gov asserts that this medical trial is presently enrolling participants. The study was posted on March 11th 2022 and amended most recently on March 17th 2022. There are 30 slots available at a single location."

Answered by AI

Are there any vacancies for this clinical experiment available at the moment?

"Affirmative. Clinicaltrials.gov's registry indicates that this experiment is currently enrolling participants, which began on March 11th 2022 and has since been revised as of the 17th of such month. A total of 30 patients need to be enlisted from a single site."

Answered by AI
~6 spots leftby Apr 2025